skip navigation links
National Cancer Institute
Enterprise Vocabulary Services
Box
NCIm Version: 201808 (Browser Version 2.9, using LexEVS 6.5.1)
SearchBox Top
SearchBox Bottom
Postpoliomyelitis Syndrome (CUI C0080040) Suggest changes to this concept
Add to Cart

Terms & Properties

Concept Unique Identifier (CUI): C0080040

Semantic Type: Disease or Syndrome

GARD Definition: Post polio syndrome (PPS) is a condition that affects polio survivors years after recovery from the initial polio illness. Symptoms and severity vary among affected people and may include muscle weakness and a gradual decrease in the size of muscles (atrophy); muscle and joint pain; fatigue; difficulty with gait; respiratory problems; and/or swallowing problems.  Only a polio survivor can develop PPS. While polio is a contagious disease, PPS is not. The exact cause of PPS years after the first episode of polio is unclear, although several theories have been proposed. Treatment focuses on reducing symptoms and improving quality of life. - this information is from GARD/ORDR/NCATS.

MSH Definition: A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. (From Ann NY Acad Sci 1995 May 25;753:68-80)

Synonyms & Abbreviations: (see Synonym Details)
Muscular Atrophies, Post-Poliomyelitis
Muscular Atrophies, Postpoliomyelitis
MUSCULAR ATROPHY POSTPOLIO
Muscular Atrophy, Post-Poliomyelitis
Muscular Atrophy, Postpoliomyelitis
Polio late effects
POST POLIO MUSCULAR ATROPHY
Post Polio syndrome
Post Poliomyelitis Muscular Atrophy
Post poliomyelitis syndrome (disorder)
Post Poliomyelitis Syndrome
Post-polio muscular atrophy
Post-polio progressive muscular atrophy
Post-polio sequelae
Post-Polio Syndromes
Post-polio Syndrome
Post-poliomyelitic syndrome
Post-Poliomyelitis Muscular Atrophies
Post-Poliomyelitis Muscular Atrophy
Post-Poliomyelitis Syndrome
Postpolio muscular atrophy
postpolio syndrome
Postpoliomyelitis Muscular Atrophies
Postpoliomyelitis Muscular Atrophy
Postpoliomyelitis Syndrome [Disease/Finding]
Postpoliomyelitis syndrome
PPMA
Progressive muscular atrophy following poliomyelitis

External Source Codes:  (none)

Other Properties: Property Definitions
Name Value Source
ACTIVE 1 SNOMEDCT_US
AN DF: POSTPOLIO SYNDROME or PPMA MSH
AQL BL CF CI CL CO DG DH DI DT EC EH EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI MSH
CASE_SIGNIFICANCE_ID 900000000000448009 SNOMEDCT_US
CHARACTERISTIC_TYPE_ID 900000000000011006 SNOMEDCT_US
CTV3ID X002p SNOMEDCT_US
DATE_CREATED 2013-01-09T00:04:00 GARD
DATE_CREATED 2014-01-05T00:11:00 GARD
DATE_LAST_MODIFIED 2013-01-09T00:04:00 GARD
DATE_LAST_MODIFIED 2014-01-05T00:11:00 GARD
DC 1 MSH
DEFINITION_STATUS_ID 900000000000074008 SNOMEDCT_US
DID 2042-5623 CSP
DISEASE_IDENTIFIER_ID 14211 GARD
DISEASE_IDENTIFIER_ID 14212 GARD
DISEASE_IDENTIFIER_ID 14213 GARD
DISEASE_IDENTIFIER_ID 14214 GARD
DISEASE_IDENTIFIER_ID 14215 GARD
DISEASE_IDENTIFIER_ID 24178 GARD
DX 19910101 MSH
EFFECTIVE_TIME 20020131 SNOMEDCT_US
EXCLUDES1 sequelae of poliomyelitis (B91) ICD10CM
FX D011051 MSH
HAS_GARD_PAGE true GARD
HN 1991 MSH
IAN DEFAULT ICD10
IDENTIFIER_SOURCE Med GARD
IDENTIFIER_TYPE_ID 1 GARD
INCLUSION_TERM Postpolio myelitic syndrome ICD10
IS_ACTIVE true GARD
IS_RARE true GARD
IS_SPANISH false GARD
LAST_REVIEW_ACTION Modified GARD
MDA 19991108 MSH
MESH_DEFINITION A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. (From Ann NY Acad Sci 1995 May 25;753:68-80) NDFRT
MESH_DUI D016262 NDFRT
MESH_NAME Postpoliomyelitis Syndrome NDFRT
MESH_UI M0024855 NDFRT
MMR 20150623 MSH
MN C02.782.687.359.764.650 MSH
MN C05.651.534.750 MSH
MN C10.228.228.618.750.750 MSH
MN C10.228.854.525.850.750 MSH
MN C10.574.827 MSH
MN C10.668.491.175.750 MSH
MN C10.668.864.500 MSH
MODIFIER_ID 900000000000451002 SNOMEDCT_US
NDFRT_KIND DISEASE_KIND NDFRT
NUI N0000003388 NDFRT
ORDER_NO 05820 ICD10CM
PM 1991 MSH
PRIMARY_PATH 10036239$10028525$10007951$10029205$Post polio syndrome$Myelitis (incl infective)$Central nervous system infections and inflammations$Nervous system disorders MDR
PRIMARY_SOC 10029205 MDR
PT_IN_VERSION 10.0 MDR
PT_IN_VERSION 10.1 MDR
PT_IN_VERSION 11.0 MDR
PT_IN_VERSION 11.1 MDR
PT_IN_VERSION 12.0 MDR
PT_IN_VERSION 12.1 MDR
PT_IN_VERSION 13.0 MDR
PT_IN_VERSION 13.1 MDR
PT_IN_VERSION 14.0 MDR
PT_IN_VERSION 14.1 MDR
PT_IN_VERSION 15.0 MDR
PT_IN_VERSION 15.1 MDR
PT_IN_VERSION 16.0 MDR
PT_IN_VERSION 16.1 MDR
PT_IN_VERSION 17.0 MDR
PT_IN_VERSION 17.1 MDR
PT_IN_VERSION 18.0 MDR
PT_IN_VERSION 18.1 MDR
PT_IN_VERSION 19.0 MDR
PT_IN_VERSION 19.1 MDR
PT_IN_VERSION 20.0 MDR
PT_IN_VERSION 20.1 MDR
PT_IN_VERSION 8.0 MDR
PT_IN_VERSION 8.1 MDR
PT_IN_VERSION 9.0 MDR
PT_IN_VERSION 9.1 MDR
RARE_DISEASE_URL http://rarediseases.info.nih.gov/gard/4454/post-polio-syndrome/resources/1 GARD
RXAUI 3200339 RXNORM
RXAUI 3222715 RXNORM
RXAUI 3222718 RXNORM
RXAUI 3222719 RXNORM
RXAUI 3222910 RXNORM
RXAUI 3222911 RXNORM
RXAUI 3222912 RXNORM
RXCUI 987839 RXNORM
SNOMED_CID 31097004 NDFRT
SUBSET_MEMBER 447562003~CORRELATIONID~447561005 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPADVICE~ALWAYS G14 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPCATEGORYID~447637006 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPGROUP~1 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPPRIORITY~1 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPRULE~TRUE SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPTARGET~G14 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~CORRELATIONID~447561005 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPADVICE~ALWAYS G14 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPCATEGORYID~447637006 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPGROUP~1 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPPRIORITY~1 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPRULE~TRUE SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPTARGET~G14 SNOMEDCT_US
SUBSET_MEMBER 900000000000497000~MAPTARGET~X002p SNOMEDCT_US
SUBSET_MEMBER 900000000000508004~ACCEPTABILITYID~900000000000548007 SNOMEDCT_US
SUBSET_MEMBER 900000000000508004~ACCEPTABILITYID~900000000000549004 SNOMEDCT_US
SUBSET_MEMBER 900000000000509007~ACCEPTABILITYID~900000000000548007 SNOMEDCT_US
SUBSET_MEMBER 900000000000509007~ACCEPTABILITYID~900000000000549004 SNOMEDCT_US
TERMUI T048449 MSH
TERMUI T048450 MSH
TERMUI T048451 MSH
TERMUI T048452 MSH
TERMUI T048453 MSH
TERMUI T369253 MSH
TH NLM (1991) MSH
TH NLM (2000) MSH
TYPE_ID 900000000000003001 SNOMEDCT_US
TYPE_ID 900000000000013009 SNOMEDCT_US

Additional Concept Data:  (none)

URL to Bookmark: https://ncim-stage.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI Metathesaurus&code=C0080040

Mainbox Bottom